MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment

• by Alejandro Lopez-Saavedra, José Díaz-Chávez, Miguel Angel Jimenez-Ríos, Anna Scavuzzo

• June 11, 2026

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

• by Mayu Watanabe, Jun Eguchi, Atsushi Takamoto, Jun Wada

• June 10, 2026

Precision Diagnostics and the ADC Revolution

Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics

• June 10, 2026

• 15 min

Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary

• by Shruti K. Gohil, Taliser R. Avery, Ken Kleinman, Edward Septimus, Amarah Mauricio, Kenneth E. Sands, Neha Varma, Selsebil Sljivo, Kaleb Roemer, William S. Cooper, Russell E. Poland, Robert A. Weinstein, Samir M. Fakhry, Jeffrey Guy, Julia Moody, Micaela H. Coady, Kim N. Smith-Sells, Mary K. Hayden, David W. Kubiak, Chenette Burks, Richard Platt, Susan S. Huang, Meghan A. Baker

• June 10, 2026